Young cancer survivors in Europe get increased post-cure help
As medical advances in oncology enable more patients to beat tumors, greater attention is being paid to secondary effects from treatment.
Sep 25, 2023
0
27
MeSH tree: C04.557.450.795.620
As medical advances in oncology enable more patients to beat tumors, greater attention is being paid to secondary effects from treatment.
Sep 25, 2023
0
27
For six years, Professor Christopher Vakoc's lab at Cold Spring Harbor Laboratory has been on a mission to transform sarcoma cells into regularly functioning tissue cells. Sarcomas are cancers that form in connective tissues ...
Aug 28, 2023
0
365
Children who lived closer to natural gas wells in heavily drilled western Pennsylvania were more likely to develop a relatively rare form of cancer, and nearby residents of all ages had an increased chance of severe asthma ...
Aug 15, 2023
0
44
Pioneering work in comparative oncology continues at UC Davis with the launch of a Canine Tumor Genome Atlas, the first genomic data bank of its kind outside of one developed by the National Cancer Institute. Eventually it ...
Aug 8, 2023
0
61
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options ...
Jul 10, 2023
0
40
New research has identified a potential therapeutic target and developed a unique delivery system to treat osteosarcoma, a bone cancer that primarily affects children and adolescents.
Apr 27, 2023
0
43
Peter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in fighting solid cancer tumors.
Apr 7, 2023
0
143
A new editorial paper titled "Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis" has been published in Oncotarget.
Mar 20, 2023
0
30
Tumor cells won't show their true selves in a petri dish, isolated from other cells.
Mar 20, 2023
0
42
A study published in the Journal of Orthopaedic Research has identified a bone matrix protein called Secreted phosphoprotein 24 kD (Spp24) that may help to treat osteosarcoma, the most common type of bone cancer.
Mar 8, 2023
0
34